LIM kinase-1 selectively promotes glycoprotein Ib-IX–mediated TXA2 synthesis, platelet activation, and thrombosis
Authors:
- 30 May 2013
- journal article
- Published by American Society of Hematology in Blood
- Vol. 121 (22) , 4586-4594
Abstract
Current antithrombotic drugs have an adverse effect on bleeding, highlighting the need for new molecular targets for developing antithrombotic drugs that minimally affect hemostasis. Here we show that LIMK1−/− mice have defective arterial thrombosis in vivo but do not differ from wild-type mice with respect to bleeding time. LIMK1−/− mice show a selective defect in platelet activation induced through the von Willebrand Factor (VWF) receptor, the glycoprotein Ib-IX-V complex (GPIb-IX), but not by GPIb-IX–independent platelet agonists. In fact, LIMK1−/− platelets show an enhanced reaction to certain GPIb-IX–independent agonists. The defect of LIMK1−/− platelets in GPIb-IX–mediated platelet activation is attributed to a selective inhibition in VWF/GPIb-IX–induced phosphorylation of cytosolic phospholipase A2 (cPLA2) and consequent thromboxane A2 (TXA2) production. Supplementing a TXA2 analog, U46619, corrected the defect of LIMK1−/− platelets in VWF-induced stable platelet adhesion. Although LIMK1−/− platelets also showed reduced actin polymerization after GPIb-IX–mediated platelet aggregation, actin polymerization inhibitors did not reduce TXA2 generation, but rather accelerated platelet aggregation, suggesting that the role of LIMK1 in GPIb-mediated platelet activation is independent of actin polymerization. Thus, LIMK1 plays a novel role in selectively mediating GPIb-IX–dependent TXA2 synthesis and thrombosis and represents a potential target for developing antithrombotic drugs with minimal bleeding side effect. Key Points Role for LIMK1 in GPIb-IX–dependent cPLA2 activation, TXA2 synthesis, and platelet activation independent of its role in actin polymerization. LIMK1 is important in arterial thrombosis in vivo but appears to be dispensable for hemostasis, suggesting a new antithrombotic target.Keywords
This publication has 45 references indexed in Scilit:
- Platelets, glycoprotein Ib-IX, and von Willebrand factor are required for FeCl3-induced occlusive thrombus formation in the inferior vena cava of micePlatelets, 2012
- An important role for Akt3 in platelet activation and thrombosisBlood, 2011
- von Willebrand factor–mediated platelet adhesion is critical for deep vein thrombosis in mouse modelsBlood, 2011
- Signaling During Platelet Adhesion and ActivationArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- G Protein Subunit Gα 13 Binds to Integrin α IIb β 3 and Mediates Integrin “Outside-In” SignalingScience, 2010
- Evaluation of the physiological significance of botrocetin/ von Willebrand factor in vitro signalingJournal of Thrombosis and Haemostasis, 2008
- Src family tyrosine kinase Lyn mediates VWF/GPIb-IX–induced platelet activation via the cGMP signaling pathwayBlood, 2008
- The role of Akt in the signaling pathway of the glycoprotein Ib-IX–induced platelet activationBlood, 2008
- Bruton tyrosine kinase is essential for botrocetin/VWF-induced signaling and GPIb-dependent thrombus formation in vivoBlood, 2006
- The roles of ADP and TXA2 in botrocetin/VWF‐induced aggregation of washed plateletsJournal of Thrombosis and Haemostasis, 2004